Polylaminin

Polylaminin or polyLM, is a stabilized form of laminin, a family of natural proteins, which is being studied for use in treating spinal cord injuries in animals and humans.[1][2][3] In early human trials, a patient with a fractured neck vertebrae after a car accident had a full recovery after a year, and a chronic quadriplegic patient regained arm movement.[4][5][6]

References

  1. ^ "Groundbreaking Brazilian Drug, Considered Capable of Reversing Spinal Cord Injury, Presented in São Paulo".
  2. ^ "Return of Voluntary Motor Contraction After Complete Spinal Cord Injury: A Pilot Human Study on Polylaminin".
  3. ^ "Brazilian scientists use placenta protein to restore some movement in dogs and humans with spinal cord injuries".
  4. ^ "Cristália drug offers hope for quadriplegia patients".
  5. ^ National Cancer Institute (2023-04-04). "The case of polylaminin in the treatment of spinal cord injuries". YouTube. Retrieved 2025-10-03.
  6. ^ National Cancer Institute (2025-10-30). "Polylaminin: The Brazilian discovery that could transform the treatment of spinal cord injuries". YouTube. Retrieved 2025-10-03.
This article is issued from Wikipedia. The text is available under Creative Commons Attribution-Share Alike 4.0 unless otherwise noted. Additional terms may apply for the media files.